Acumen Pharmaceuticals Inc (ABOS)
3.19
+0.01
(+0.31%)
USD |
NASDAQ |
Apr 25, 16:00
3.185
0.00 (0.00%)
Pre-Market: 20:00
Acumen Pharmaceuticals Total Assets (Quarterly): 310.12M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 310.12M |
| September 30, 2023 | 286.37M |
| June 30, 2023 | 177.40M |
| March 31, 2023 | 187.86M |
| December 31, 2022 | 196.59M |
| September 30, 2022 | 203.26M |
| June 30, 2022 | 211.68M |
| Date | Value |
|---|---|
| March 31, 2022 | 220.09M |
| December 31, 2021 | 230.33M |
| September 30, 2021 | 234.85M |
| June 30, 2021 | 72.94M |
| March 31, 2021 | 42.37M |
| December 31, 2020 | 44.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
42.37M
Minimum
Mar 2021
310.12M
Maximum
Dec 2023
186.02M
Average
203.26M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Accuray Inc | 476.35M |
| Johnson & Johnson | 167.56B |
| Kezar Life Sciences Inc | 221.24M |
| Akoya Biosciences Inc | 180.37M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 43.15M |
| Shareholders Equity (Quarterly) | 266.97M |